Rice Hall James & Associates LLC Purchases 131,023 Shares of Aspen Aerogels, Inc. $ASPN

Posted by Brenda Bartman on Jul 26th, 2026

Rice Hall James & Associates LLC boosted its position in Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) by 9.2% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,552,628 shares of the construction company’s stock after purchasing an additional 131,023 shares during the period. Rice Hall James & Associates LLC’s holdings in Aspen Aerogels were worth $5,310,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Tudor Investment Corp ET AL acquired a new stake in shares of Aspen Aerogels during the third quarter valued at about $3,387,000. SG Americas Securities LLC increased its stake in shares of Aspen Aerogels by 227.5% in the fourth quarter. SG Americas Securities LLC now owns 263,354 shares of the construction company’s stock valued at $745,000 after buying an additional 182,931 shares during the period. Needham Investment Management LLC raised its holdings in Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after buying an additional 912,000 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in Aspen Aerogels by 20.3% in the 4th quarter. First Eagle Investment Management LLC now owns 622,487 shares of the construction company’s stock valued at $1,762,000 after buying an additional 105,164 shares during the last quarter. Finally, Connors Investor Services Inc. raised its holdings in Aspen Aerogels by 37.3% in the 4th quarter. Connors Investor Services Inc. now owns 55,167 shares of the construction company’s stock valued at $156,000 after buying an additional 15,000 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ASPN has been the topic of a number of research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Roth Capital reaffirmed a “buy” rating and set a $5.75 price target on shares of Aspen Aerogels in a research note on Friday, May 8th. Barclays raised their price target on shares of Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research note on Monday, May 11th. Finally, Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Aspen Aerogels has a consensus rating of “Hold” and an average target price of $5.19.

View Our Latest Report on ASPN

Aspen Aerogels Trading Down 9.6%

Shares of ASPN stock opened at $4.67 on Friday. Aspen Aerogels, Inc. has a 1-year low of $2.30 and a 1-year high of $9.78. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. The stock has a market cap of $386.64 million, a price-to-earnings ratio of -3.43 and a beta of 2.98. The stock has a 50-day moving average of $5.66 and a 200-day moving average of $4.31.

Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The company had revenue of $37.88 million during the quarter, compared to analyst estimates of $36.58 million. During the same period in the prior year, the firm earned ($0.06) earnings per share. Aspen Aerogels’s revenue was down 51.8% compared to the same quarter last year. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. On average, equities research analysts forecast that Aspen Aerogels, Inc. will post -0.8 earnings per share for the current year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.